Literature DB >> 24648982

Effects of tumor microenviromental factors on VEGF expression.

Feng Wang1, Ping Xu1, Kuang-Chen Xie1, Xia-Fang Chen1, Chuan-Yuan Li2, Qian Huang1.   

Abstract

The expression of vascular endothelial growth factor (VEGF) is regulated by microenvironmental factors within the tumors, such as hypoxia, free radicals, pH imbalance and nutrient deficiency. The purpose of this study was to observe VEGF activity in tumor cells under different stress conditions. A plasmid was generated, consisting of green fluorescent protein (GFP) fused to a 1,217-bp sequence, which was located downstream and upstream of the transcriptional start site of VEGF, respectively. The plasmid was stably transfected into 4T1 mouse breast carcinoma cells. Cells were cultured in a medium with nitric oxide (NO) donor sodium nitroprusside (SNP), hypoxia-mimetic agent deferoxamine mesylate (DFX), H2O2, absence of serum and lowered or elevated pH, or were heat-shocked, followed by measurement of VEGF activity by reverse transcription polymerase chain reaction (RT-PCR) and ELISA. Hypoxia, SNP and H2O2 led to increments of VEGF mRNA and protein expression, as well as of GFP expression. The pH alterations, serum deprivation and heat shock reduced VEGF mRNA expression, but had little effect on GFP expression. The results demonstrated that VEGF expression may be influenced by a number of microenvironmental factors and these factors may play important roles in regulating VEGF expression during tumorigenesis.

Entities:  

Keywords:  free radical; microenvironment; tumor cells; vascular endothelial growth factor promoter

Year:  2013        PMID: 24648982      PMCID: PMC3916990          DOI: 10.3892/br.2013.115

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  23 in total

1.  Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.

Authors:  N Koshikawa; K Takenaga; M Tagawa; S Sakiyama
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

2.  Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.

Authors:  Ling-Zhi Liu; Xiao-Wen Hu; Chang Xia; Jie He; Qiong Zhou; Xianglin Shi; Jing Fang; Bing-Hua Jiang
Journal:  Free Radic Biol Med       Date:  2006-08-07       Impact factor: 7.376

3.  Relationships between vascularization and proliferation in invasive breast cancer.

Authors:  J A Beliën; P J van Diest; J P Baak
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

4.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

5.  Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells.

Authors:  Y D Jung; K Nakano; W Liu; G E Gallick; L M Ellis
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

6.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells.

Authors:  E Ikeda; M G Achen; G Breier; W Risau
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

8.  Desferrioxamine-driven upregulation of angiogenic factor expression by human bone marrow stromal cells.

Authors:  Esther Potier; Elisabeth Ferreira; Sylviane Dennler; Alain Mauviel; Karim Oudina; Delphine Logeart-Avramoglou; Hervé Petite
Journal:  J Tissue Eng Regen Med       Date:  2008-07       Impact factor: 3.963

9.  The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences.

Authors:  D T Shima; M Kuroki; U Deutsch; Y S Ng; A P Adamis; P A D'Amore
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

10.  Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine.

Authors:  G Melillo; L S Taylor; A Brooks; T Musso; G W Cox; L Varesio
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

View more
  5 in total

1.  Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model.

Authors:  Ying Chen; Xianfei Hong
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

2.  Formulation and Pathohistological Study of Mizolastine-Solid Lipid Nanoparticles-Loaded Ocular Hydrogels.

Authors:  Ghada Ahmed El-Emam; Germeen N S Girgis; Mohammed Fawzy Hamed; Osama Abd El-Azeem Soliman; Abd El Gawad H Abd El Gawad
Journal:  Int J Nanomedicine       Date:  2021-11-24

3.  Suicide gene therapy-mediated purine nucleoside phosphorylase/fludarabine system for in vitro breast cancer model with emphasis on evaluation of vascular endothelial growth factor promoter efficacy.

Authors:  Akbar Abbaspour; Abdolreza Esmaeilzadeh; Ali Sharafi
Journal:  3 Biotech       Date:  2021-02-24       Impact factor: 2.406

4.  Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches.

Authors:  T Jazedje; A L Ribeiro; M Pellati; H M de Siqueira Bueno; G Nagata; M Trierveiler; E G Rodrigues; M Zatz
Journal:  Stem Cells Int       Date:  2015-04-27       Impact factor: 5.443

5.  Intratumoral Treatment with 5-Androstene-3β, 17α-Diol Reduces Tumor Size and Lung Metastasis in a Triple-Negative Experimental Model of Breast Cancer.

Authors:  Rocío Alejandra Ruiz Manzano; Karen Elizabeth Nava-Castro; Margarita Isabel Palacios-Arreola; Rosalía Hernández-Cervantes; Víctor Hugo Del Río-Araiza; Mariana Segovia-Mendoza; Armando Pérez-Torres; Manuel Iván Girón-Pérez; Jorge Morales-Montor
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.